As in Denmark? The dubious preservation of biotechs in the health sector

By Sandra Romandía

In February of last year, a group of officials of the Morenista government of Tamaulipas, led by Daniel Jasso Sánchez, administrative director of the Secretariat of Urban Development and Environment (Seduma) of that entity, launched a business to sell medicines to the federal government. Grupo Osherx, they named it.

They quickly snagged a 57 million peso contract to supply drugs that included erythropoietin, a hormone that requires cold chain preservation. The medicine was produced in the Valley of Mexico and was to be delivered to IMSS warehouses in Acapulco, but Jasso Sanchez said he had his warehouses in Ciudad Victoria, which turned out to be a house in a vacant lot.